Is continuation of anti-platelet treatment safe for elective total hip arthroplasty patients?

Itay Ashkenazi*, Haggai Schermann, Aviram Gold, Ron Gurel, Ofir Chechik, Yaniv Warschawski, Ran Schwarzkopf, Nimrod Snir

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Is continuation of anti-platelet treatment safe for elective total hip arthroplasty patients?'. Together they form a unique fingerprint.

Medicine & Life Sciences